Shaaban Khaled A, Saunders Meredith A, Zhang Yinan, Tran Tuan, Elshahawi Sherif I, Ponomareva Larissa V, Wang Xiachang, Zhang Jianjun, Copley Gregory C, Sunkara Manjula, Kharel Madan K, Morris Andrew J, Hower James C, Tremblay Matthew S, Prendergast Mark A, Thorson Jon S
California Institute for Biomedical Research (Calibr) , La Jolla, California 92037, United States.
Center for Applied Energy Research, University of Kentucky , Lexington, Kentucky 40511, United States.
J Nat Prod. 2017 Jan 27;80(1):2-11. doi: 10.1021/acs.jnatprod.6b00948. Epub 2016 Dec 28.
The isolation and structure elucidation of six new bacterial metabolites [spoxazomicin D (2), oxachelins B and C (4, 5), and carboxamides 6-8] and 11 previously reported bacterial metabolites (1, 3, 9-12a, and 14-18) from Streptomyces sp. RM-14-6 is reported. Structures were elucidated on the basis of comprehensive 1D and 2D NMR and mass spectrometry data analysis, along with direct comparison to synthetic standards for 2, 11, and 12a,b. Complete 2D NMR assignments for the known metabolites lenoremycin (9) and lenoremycin sodium salt (10) were also provided for the first time. Comparative analysis also provided the basis for structural revision of several previously reported putative aziridine-containing compounds [exemplified by madurastatins A1, B1, C1 (also known as MBJ-0034), and MBJ-0035] as phenol-dihydrooxazoles. Bioactivity analysis [including antibacterial, antifungal, cancer cell line cytotoxicity, unfolded protein response (UPR) modulation, and EtOH damage neuroprotection] revealed 2 and 5 as potent neuroprotectives and lenoremycin (9) and its sodium salt (10) as potent UPR modulators, highlighting new functions for phenol-oxazolines/salicylates and polyether pharmacophores.
报道了从链霉菌属RM - 14 - 6中分离出6种新的细菌代谢产物[spoxazomicin D (2)、oxachelins B和C (4, 5)以及羧酰胺6 - 8]和11种先前报道的细菌代谢产物(1, 3, 9 - 12a以及14 - 18),并对其结构进行了鉴定。通过全面的一维和二维核磁共振以及质谱数据分析,并与2、11和12a,b的合成标准品进行直接比较来阐明结构。还首次提供了已知代谢产物lenoremycin (9)和lenoremycin钠盐(10)的完整二维核磁共振归属。对比分析还为几种先前报道的假定含氮丙啶化合物[以马杜拉他汀A1、B1、C1(也称为MBJ - 0034)和MBJ - 0035为例]的结构修正为酚二氢恶唑提供了依据。生物活性分析[包括抗菌、抗真菌、癌细胞系细胞毒性、未折叠蛋白反应(UPR)调节以及乙醇损伤神经保护作用]表明,2和5是有效的神经保护剂,lenoremycin (9)及其钠盐(10)是有效的UPR调节剂,突出了酚恶唑啉/水杨酸盐和聚醚药效团的新功能。